Views & Analysis | Perspectives on pharma industry issues

R&D

JPM2026 wrap-up with Nicole Raleigh and Jonah Comstock

On JPM2026 and healthcare investment today, with Jonah Comst...

Editor-in-chief Jonah Comstock sat down with pharmaphorum web editor Nicole Raleigh to discuss JPM2026.

Digital

Tel Aviv Sourasky Medical Center helipad and The Jerusalem Press Club

Israel’s MedTech and health innovation landscape: Part one –...

Part One of a series of articles – Israel’s MedTech and health innovation landscape: From Tel Aviv to Jerusalem - looking at resilient progress there.

R&D

Representation of bipolar and other mental health disorders, Janus concept

The role of the opioid pathway in schizophrenia and bipolar ...

Psychiatry has spent decades focused on dopamine, serotonin, norepinephrine, and glutamate.

Digital

Man shakes woman's hand in signal of a business deal

Changing Faces: Digital and supplier, January 2026

The life sciences supplier and digital health sectors witnessed significant leadership movements in January.

R&D

steaming nebulizer mask in hand instructing African American daughter

Advancing RSV and hMPV research through human challenge tria...

Human challenge trials offer a complementary approach, and hVIVO has been at the forefront of this field for decades.

Market Access

Deep Dive: Market Access 2024

In this edition of Deep Dive, Unpacking complex choreography in the biologics patent dance, Alexion examines the urgent need for accelerated access programmes for rare disease treatments, and Putna

R&D

Is precision psychiatry possible?

Anyone who has taken a psychiatric medication knows that the status quo in prescribing is a trial and error approach, with patients often cycling through an array of drugs to find the one t

R&D

Emergence of ADCs as the “hot, new technology”

The recent acquisition of ImmunoGen by AbbVie, which followed the earlier acquisition of Seagen by Pfizer, has brought renewed attention to antibody-drug conjugates (ADCs), highlighting the

Sales & Marketing

Swiss train speeding across bridge against landscape background

A fast start to 2026 signals continued investor confidence i...

Key factors in Switzerland’s success that could make other European life sciences hubs more attractive to investors.

Sales & Marketing

Woman shakes man's hand in hiring process

Changing Faces: Agency and consultancy, January 2026

The pharmaceutical services sector saw a flurry of new executive hires last month, spanning agencies, consultancies, investment firms & a few others.

Digital

Israel’s MedTech and health innovation landscape: Part one –...

Part One of a series of articles – Israel’s MedTech and health innovation landscape: From Tel Aviv to Jerusalem - looking at resilient progress there.

Digital

Changing Faces: Digital and supplier, January 2026

The life sciences supplier and digital health sectors witnessed significant leadership movements in January.

Market Access

Biotech leaders: ‘They're shoving this industry into the arm...

At the Biotech Showcase during JPM Week, biotech leaders expressed frustration at the US's lack of concern about Chinese biotech progress.

Market Access

European biopharma at a crossroads

If Europe can bridge its operational gaps while leveraging its scientific base, it can carve out a distinctive and sustainable leadership position.

Oncology

A cancer treatment modality that prioritises QoL, with Ben Z...

Immuneering's Ben Zeskind explains how, by focusing on quality of life as well as quantity, they've created a drug for pancreatic cancer.

Oncology

Improving breast cancer outcomes in sub-Saharan Africa

New funding from The Pfizer Foundation will support breast cancer efforts in Kenya by the Academic Model Providing Access to Healthcare (AMPATH).

Oncology

Engineering “smarter” cells, with Tim Lu

Senti Bio's Tim Lu discusses “logic-gated” cells, which have multiple receptors allowing them to attack cancer cells while leaving healthy cells alone